EURO-STIM Registry
Longitudinal Outcomes and Adherence of the Inspire System, EURO-STIM Registry
Inspire Medical Systems, Inc.
1,000 participants
May 26, 2025
OBSERVATIONAL
Conditions
Summary
The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.
Eligibility
Inclusion Criteria3
- Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry:
- Capable of giving informed consent, as required per institution
- Willing to return for routine clinic visits as required for Inspire therapy management
Exclusion Criteria3
- Any patient who meets any of the following criteria will not be eligible to participate in the registry:
- Has a life expectancy of less than one year
- Any reason the clinician deems patient is unfit for participation in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will be implanted with the Inspire UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06971796